Showing results (1861-1870 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|July 3, 2010
Influence of mild and moderate hepatic impairment on axitinib pharmacokineticsMichael A Tortorici, Melvin Toh, S V Rahavendran, et al.
Investigational New Drugs|July 3, 2010
Inhibition of mouse embryonic carcinoma cell growth by lidamycin through down-regulation of embryonic stem cell-like genes Oct4, Sox2 and MycHong-Ying Zhen, Qi-Hua He, Yong-Zhan Zhen, et al.
Investigational New Drugs|October 7, 2010
Riccardin D, a novel macrocyclic bisbibenzyl, induces apoptosis of human leukemia cells by targeting DNA topoisomerase IIXia Xue, Xian-Jun Qu, Zu-Hua Gao, et al.
Investigational New Drugs|October 7, 2010
Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabineTakashi Sasaki, Hiroyuki Isayama, Yousuke Nakai, et al.
Investigational New Drugs|October 7, 2010
Combining functional imaging and interstitial pressure measurements to evaluate two anti-angiogenic treatmentsIngrid Leguerney, Nathalie Lassau, Serge Koscielny, et al.
Investigational New Drugs|October 5, 2010
A novel aminosteroid of the 5α-androstane-3α,17β-diol family induces cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cellsHajer Jegham, Jenny Roy, René Maltais, et al.
Investigational New Drugs|October 5, 2010
The combination of the novel glycolysis inhibitor 3-BrOP and rapamycin is effective against neuroblastomaAlejandro G Levy, Peter E Zage, Lauren J Akers, et al.
Investigational New Drugs|July 8, 2010
The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cellsJin-Jian Lu, Si-Meng Chen, Xiao-Wei Zhang, et al.
Investigational New Drugs|August 3, 2010
Bevacizumab-induced small bowel perforation in a patient with breast cancer without intraabdominal metastasesEdouard Lecarpentier, Lamia Ouaffi, Olivier Mir, et al.
Investigational New Drugs|August 3, 2010
VEGF pathway inhibition by anticancer agent sunitinib and susceptibility to atherosclerosis plaque disruptionStanislas Ropert, Olivier Vignaux, Olivier Mir, et al.
Pageof 372